Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study
Abstract Background The prevalence of sarcopenia is increased with declining renal function. Elevated serum indoxyl sulfate levels are associated with poor skeletal muscle conditions. We aimed to determine the effects of AST‐120, the oral adsorbent of indoxyl sulfate, on sarcopenia and sarcopenia‐as...
Main Authors: | Ran‐hui Cha, Seok Hui Kang, Mi Yeun Han, Won Suk An, Su‐Hyun Kim, Jun Chul Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12874 |
Similar Items
-
Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes
by: Yasuhiko Tomino, et al.
Published: (2018-06-01) -
A Metabolomic Approach to Clarifying the Effect of AST-120 on 5/6 Nephrectomized Rats by Capillary Electrophoresis with Mass Spectrometry (CE-MS)
by: Takaaki Abe, et al.
Published: (2012-11-01) -
Improvement of microcirculatory impairment in patients with predialysis chronic kidney disease after AST-120 administration
by: Takayasu Ohtake, et al.
Published: (2020-06-01) -
Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients
by: Mayumi Asai, et al.
Published: (2019-01-01) -
Prevalence of sarcopenia and its associated factors: the impact of muscle mass, gait speed, and handgrip strength reference values on reported frequencies
by: Virgílio Garcia Moreira, et al.
Published: (2019-04-01)